Unichem Lab inks agreement to acquire 20% stake in Optimus group

06 Nov 2018 Evaluate

Unichem Laboratories has entered into an agreement to acquire 20% equity stake in the API and intermediate business of Hyderabad based Optimus group. The acquisition value is Rs 120 crore.

The transaction will give the company access to Optimus' US Food and Drug Administration (USFDA) approved API manufacturing facilities and Optimus will gain from the extensive knowledge base and industry best practices of Unichem.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Unichem Lab Share Price

431.45 -11.25 (-2.54%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×